Prelude Therapeutics INC (PRLD) — SC 13G/A Filings
All SC 13G/A filings from Prelude Therapeutics INC. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (4)
- SC 13G/A Filing — Feb 13, 2024
-
Prelude Therapeutics: Dr. Krishna Vaddi Holds 10% Stake
— Feb 12, 2024 Risk: low
Dr. Krishna Vaddi, a key figure at Prelude Therapeutics Inc., filed an amended SC 13G/A on February 12, 2024, disclosing his beneficial ownership of 4,908,086 s -
Deerfield Mgmt Discloses 4.13M Shared Vote in Prelude Therapeutics
— Feb 12, 2024 Risk: low
Deerfield Management Company, L.P. and its affiliates, including Deerfield Mgmt, L.P. and Deerfield Partners, L.P., filed an amended SC 13G/A on February 12, 20 -
FMR LLC Cuts Prelude Therapeutics Stake to 0.630%
— Jan 10, 2024
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have significantly reduced their stake in Prelude Therapeutics Inc. As of January 10, 2024, t
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX